drugset
drugset / Trial / NCT03241043

Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients

NCT03241043 ↗

Phase 3 Completed 20 enrolled University Medical Center Hamburg-Eppendorf
RandomizedCrossoverOpen-labelTreatment

Summary

Single centre, open-label, randomized, controlled, cross over study to evaluate the pharmacokinetic and bioavailability of Envarsus® in comparison to Advagraf® in de novo liver transplant recipients

Timeline

Start
2016-05
Primary completion
2019-04
Completion
2019-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule — —

Indications

No indication recorded.